Blumenfeld, Carl M.
Schulz, Michael D.
Aboian, Mariam S.
Wilson, Mark W.
Moore, Terilynn
Hetts, Steven W.
Grubbs, Robert H.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (5T32EB001631-13, R01CA194533)
Article History
Received: 12 May 2017
Accepted: 20 June 2018
First Online: 20 July 2018
Competing interests
: S.W.H. and M.W.W. have a royalty agreement through the University of California and currently licensed to Penumbra, Inc., should a medical device resulting from the underlying endovascular filtration technology be developed and marketed. A patent application (WO2018048829A1) has been filed by the California Institute of Technology that covers the materials described in this paper. The remaining authors declare no competing interests.